NCT05980234View on ClinicalTrials.gov

MDR - Longevity IT Oblique and Offset Liners

TerminatedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

August 30, 2023

Primary Completion Date

November 2, 2024

Study Completion Date

November 7, 2024

Conditions
Non-inflammatory Degenerative Joint Disease (NIDJD)Avascular NecrosisProtrusio AcetabuliTraumatic ArthritisSlipped Capital Femoral EpiphysesFracture of the PelvisDiastrophic VariantOsteoarthritisFused Hip
Interventions
DEVICE

Total Hip Arthroplasty with Longevity IT Oblique Liners

Primary or Revision Total Hip Arthroplasty using the Longevity IT Oblique liners according to the approved indications and compatible device.

DEVICE

Total Hip Arthroplasty with Longevity IT Offset Liners

Primary or Revision Total Hip Arthroplasty using the Longevity IT Offset liners according to the approved indications and compatible device.

Trial Locations (1)

19107

Rothman Institute, Philadelphia

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY